Simge ERDEM

About Simge ERDEM

Simge ERDEM, With an exceptional h-index of 6 and a recent h-index of 4 (since 2020), a distinguished researcher at Istanbul Üniversitesi, specializes in the field of Hematology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction

P-425 Cardiac AL amyloidosis experienced in the last decade from a single center

MPN-227 Insight into Hypereosinophilia from the Hematology Clinic; A Single-Center Experience

CLL-079 The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)

MM-224 A Rare Case of Multiple Myeloma Presenting as a Cranial Nerve Palsy

MM-228 A Different Point of View: Facial Paralysis as a Manifestation of AL Amyloidosis

CT-150 COVID-19 Vaccination–Associated Acquired Thrombotic Thrombocytopenic Purpura (TTP)

MPN-140 The Role of 18F-FDG PET/CT Scan in Adult Langerhans Cell Histiocytosis: A Single-Center Experience

Simge ERDEM Information

University

Position

Istanbul Medical Faculty

Citations(all)

206

Citations(since 2020)

111

Cited By

113

hIndex(all)

6

hIndex(since 2020)

4

i10Index(all)

4

i10Index(since 2020)

3

Email

University Profile Page

Google Scholar

Simge ERDEM Skills & Research Interests

Hematology

Top articles of Simge ERDEM

Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction

Turkish Journal of Hematology

2024/3

Simge Erdem
Simge Erdem

H-Index: 4

P-425 Cardiac AL amyloidosis experienced in the last decade from a single center

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Simge Erdem
Simge Erdem

H-Index: 4

MPN-227 Insight into Hypereosinophilia from the Hematology Clinic; A Single-Center Experience

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Simge Erdem
Simge Erdem

H-Index: 4

CLL-079 The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Simge Erdem
Simge Erdem

H-Index: 4

MM-224 A Rare Case of Multiple Myeloma Presenting as a Cranial Nerve Palsy

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Yunus Çatma
Yunus Çatma

H-Index: 3

Simge Erdem
Simge Erdem

H-Index: 4

MM-228 A Different Point of View: Facial Paralysis as a Manifestation of AL Amyloidosis

Clinical Lymphoma, Myeloma and Leukemia

2023/9/1

Simge Erdem
Simge Erdem

H-Index: 4

CT-150 COVID-19 Vaccination–Associated Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Simge Erdem
Simge Erdem

H-Index: 4

MPN-140 The Role of 18F-FDG PET/CT Scan in Adult Langerhans Cell Histiocytosis: A Single-Center Experience

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Simge Erdem
Simge Erdem

H-Index: 4

P939: THE RELATIONSHIP OF BONE MARROW FIBROSIS WITH EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA

HemaSphere

2023/8/1

Emine Göknur Işik
Emine Göknur Işik

H-Index: 5

Simge Erdem
Simge Erdem

H-Index: 4

Evaluation of Thromboembolism Risk in Patients with Cancer; Single Center Real-life Data

Istanbul Medical Journal= Istanbul Tip Dergisi

2023/5/1

Simge Erdem
Simge Erdem

H-Index: 4

Muhlis Cem Ar
Muhlis Cem Ar

H-Index: 11

Comprehensive mastocytosis data analysis from a single center

BMC cancer

2023/1/24

Simge Erdem
Simge Erdem

H-Index: 4

Can Baykal
Can Baykal

H-Index: 12

Erişkin Yaşamda Hemoglobinopatili Hasta İzlem ve Tedavisi

Turkiye Klinikleri Pediatric Hematology and Oncology-Special Topics

2023

Simge Erdem
Simge Erdem

H-Index: 4

Turk J Hematol

2023/12/22

Simge Erdem
Simge Erdem

H-Index: 4

CUTANEOUS RICHTER TRANSFORMATION IN THE 16TH YEAR OF FOLLICULAR LYMPHOMA DIAGNOSIS

Hematology, Transfusion and Cell Therapy

2023/10/1

Simge Erdem
Simge Erdem

H-Index: 4

INFECTION RATES ACROSS THE AUTOLOGOUS STEM CELL TRANSPLANTATION WITH REFLECTION OF MULTIPLE MYELOMA INDUCTION STORY IN TURKEY

Hematology, Transfusion and Cell Therapy

2023/10/1

Simge Erdem
Simge Erdem

H-Index: 4

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Turkish Journal of Hematology

2022/12

TREATMENT OF A PATIENT DIAGNOSED WITH ERDHEIM CHESTER'S DISEASE IN COOPERATION WITH PLASTIC SURGERY AND HEMATOLOGY

Hematology, Transfusion and Cell Therapy

2022/10/1

Simge Erdem
Simge Erdem

H-Index: 4

A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS; PULMONARY AL AMYLOIDOSIS

Hematology, Transfusion and Cell Therapy

2022/10/1

Simge Erdem
Simge Erdem

H-Index: 4

AN UNUSUAL OCULAR LYMPHOMA, PRIMARY INTRAVITREAL LYMPHOMA DIAGNOSED INCIDENTALLY

Hematology, Transfusion and Cell Therapy

2022/10/1

Simge Erdem
Simge Erdem

H-Index: 4

GLOMERULAR MICROANGIOPATHY WITH MARKED SYSTEMIC THROMBOTIC MICROANGIOPATHY SHORTLY AFTER BORTEZOMIB IN A NEWLY DIAGNOSED POEMS SYNDROME PATIENT

Hematology, Transfusion and Cell Therapy

2022/10/1

Simge Erdem
Simge Erdem

H-Index: 4

See List of Professors in Simge ERDEM University(Istanbul Üniversitesi)